跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gemcitabine IV Infusion 200 mg/ 5.3 mL Hospira - TGA Drug Approval Details
Approvals
/
TGA
/
Gemcitabine IV Infusion 200 mg/ 5.3 mL Hospira
Approved
STANDARD
Gemcitabine IV Infusion 200 mg/ 5.3 mL Hospira
Hospira Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
6e1aa1baa53e6c4e
Company
Hospira Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
6e1aa1baa53e6c4e
Product Name
Gemcitabine IV Infusion 200 mg/ 5.3 mL Hospira
Artg Id
260666
Artg Name
Gemcitabine IV Infusion 200 mg/ 5.3 mL Hospira
Sponsor
Hospira Australia Pty Ltd
Company Detail Path
/organization/hospira-australia-pty-ltd
Artg Date
2015-10-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
6e1aa1baa53e6c4e
Type
Standard
Back to TGA Approvals
